glp-1 osteoporosis Frontiers Frontiers | Effect of gut
Description
The clinical effects of the medication are similar to GLP-1 RAs
Its made by specialty pharmacies instead of big pharma companies
The Injection Technique Factor: What You Don't Know or Teach Can Make a Difference
Research shows: Slowed progression of chronic kidney disease (CKD) Reduced proteinuria (albumin in urine) , an early marker of kidney damage Improved kidney filtration rates over time The FLOW trial with semaglutide demonstrated that GLP-1 therapy could significantly reduce the risk of kidney failure in patients with type 2 diabetes and CKD
Consent for publication: Not applicable
